Hydrogenology
Hydrogenology editorial study record

Transperitoneal administration of dissolved hydrogen for peritoneal dialysis patients: a novel approach to suppress oxidative stress in the peritoneal cavity

Terawaki H, Hayashi Y, Zhu WJ, Matsuyama Y, Terada T, Kabayama S, Watanabe T, Era S, Sato B, Nakayama M. · 2013.

HumanOther formsPublished 2013
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Human

Reported design

Uncontrolled acute pilot study

Research topic

Kidney and urinary health

Administration classification

Other forms

Study result signal

Exploratory within-person biomarker signal.

Outcome type

Short-term laboratory surrogate and safety observations.

Reported in the source

Methods at a glance

Population or model

Six adults receiving peritoneal dialysis.

Sample

6 patients.

Duration

Single administration with serial sampling over the dialysis session.

Intervention

A single peritoneal-dialysis session using hydrogen-enriched dialysate.

Hydrogen form

H₂ dissolved in dialysis solution.

H₂ specification

The article reports dialysate preparation and measured exposure; no inhaled gas was used.

H₂ flow

Not applicable.

O₂ delivered with H₂

No oxygen was co-delivered.

Comparator

Within-person measurements before and after exposure; no concurrent control group.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Peritoneal and plasma redox-state markers and immediate tolerability.

Reported result

The report describes changes in albumin redox-state measures after the hydrogen-enriched dialysate and no immediate detrimental effect in this small pilot.

Results-extraction completeness

The full article was checked for methods, intervention details, outcomes, positive and null findings, funding and conflicts. This record does not imply medical efficacy.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Six-person uncontrolled pilot with surrogate outcomes and no evidence about clinical events.

Applies directly to

Peritoneal-dialysis patients under this single-session protocol.

Preliminary appraisal framework

ROBINS-I — preliminary

Preliminary risk-of-bias status

Serious concerns

Appraisal rationale

No concurrent comparator, very small sample and short biomarker follow-up create serious confounding and imprecision.

Appraisal domains

Selection and allocation checked · Confounding and co-interventions remain possible · Missing observations checked where reported · Outcome measurement varies by endpoint · Selective reporting cannot be excluded

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 23816239 · DOI: 10.1186/2045-9912-3-14

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official PubMed Central full article and PubMed bibliographic record; source identity, methods, intervention, results, funding and conflicts checked 10 August 2026.

Record revision

2026-08-10